11:31

World Multiple Sclerosis Day 2024: Brett's MS Journey

04:21

Announcement: New Multiple Sclerosis Research Communications Collaboration

08:57

MS Milan 2023: Research Insights from Day Three

21:05

MS Milan 2023: Research Insights from Day Two

19:14

MS Milan 2023: Research Insights from Day One

08:26

Thoughts on Multiple Sclerosis: Mental Health, Exercise & Treatments

08:58

COVID-19 Infection and Multiple Sclerosis

02:53

Multiple Sclerosis Remyelination Trial Update: Metformin and Clemastine

22:01

ECTRIMS 2022: Remyelination Research Insights - Dr Travis Stiles & A/Prof Alban Gaultier

09:56

The Value of Specialist Multiple Sclerosis Nurses: Study Outcomes

17:22

ECTRIMS 2022: Research Insights from Day Three

15:01

ECTRIMS 2022: Research Insights from Day Two

16:01

ECTRIMS 2022: Research Insights from Day One

03:45

Exciting ECTRIMS 2022 Announcement

55:56

Facebook Live Q&A: Special Announcement & Multiple Sclerosis Research Discussion

09:17

How Could Epstein-Barr Virus Trigger Multiple Sclerosis?

06:48

Understanding Science: What is a Biomarker?

05:01

Multiple Sclerosis Research: Understanding Anxiety, Depression & Sexual Dysfunction

54:17

Remyelination & Multiple Sclerosis with Novoron Bioscience

24:01

Multiple Sclerosis Limited Podcast: Remyelination Research Insights

19:31

Multiple Sclerosis Research: ACTRIMS 2022 Update with Dr Barry Singer

10:11

Does Drinking Cow’s Milk Worsen Multiple Sclerosis Symptoms?

08:56

Diet & Multiple Sclerosis: Swank vs Wahls Study

01:03:44

Facebook Live Q&A: Epstein-Barr Virus & Multiple Sclerosis

11:29

Epstein-Barr Virus as a Treatment Target in Multiple Sclerosis

12:51

Is Epstein-Barr Virus the Cause of Multiple Sclerosis?

10:23

COVID-19 Update: Infection Risk & Vaccine Efficacy in Multiple Sclerosis

12:42

Real World Application of Stem Cell Transplantation in Multiple Sclerosis

42:42

Surplus Suffering in Multiple Sclerosis

46:09

Multiple Sclerosis & Remyelination Research

03:02

Study Recruitment: Cognition in People Living with Multiple Sclerosis

03:03

Multiple Sclerosis Research - Staying Up To Date

36:53

Multiple Sclerosis Limited Podcast: ECTRIMS 2021 Research Insights

17:54

ECTRIMS 2021: Research Insights from Day Three

14:50

ECTRIMS 2021: Research Insights from Day Two

16:07

ECTRIMS 2021: Research Insights from Day One

03:04

Special Announcement: Dr Travis Stiles Joins MStranslate

06:27

Why Don't We Have a Cure for Multiple Sclerosis?

06:49

COVID-19 Vaccines and Multiple Sclerosis

05:29

Multiple Sclerosis and The Blood-Brain Barrier

04:48

Redefining A Cure For Multiple Sclerosis

09:28

Multiple Sclerosis Research: Constipation and MS

04:17

A Special Announcement by MStranslate

23:29

Sex Differences Research In Multiple Sclerosis

09:26

ACTRIMS Forum 2021 - Overview of Day 3

09:49

ACTRIMS Forum 2021 - Overview of Day 2

09:41

ACTRIMS Forum 2021 - Overview of Day 1

07:41

The Gut Microbiome In Multiple Sclerosis - New Research Findings

07:20

Childhood Trauma & Multiple Sclerosis: A Study Overview

16:32

MS Virtual 2020: The Role of Infections in Multiple Sclerosis - Kelsi Smith

01:27:39

Facebook Live: mRNA Vaccines & Multiple Sclerosis - January 19 2021

06:30

mRNA Vaccines & Their Potential In Multiple Sclerosis

10:59

MS Virtual 2020: Wearable Technology in Multiple Sclerosis - Sarah Alexander

26:31

MS Virtual 2020: The Gut Microbiome - A Novel Treatment Approach for MS - Dr Shailesh Shahi

13:20

MS Virtual 2020: Environmental Risk Factors in Multiple Sclerosis - Dr. Kassandra Munger

14:05

MS Virtual 2020: Multiple Sclerosis International Federation - Atlas of MS - Clare Walton

22:35

MS Virtual 2020: Remyelination Clinical Trial Results - Bexarotene - Dr Will Brown

20:44

MS Virtual 2020: Exploring the Gut Microbiome in Multiple Sclerosis - Mary Horton, MPH

27:34

MS Virtual 2020: Introducing RealTalk MS - Jon Strum

18:14

MS Virtual 2020: The Multiple Sclerosis Prodrome - Prof. Helen Tremlett